Glycorex Transplantation Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Glycorex Transplantation
Access all reports
Glycorex Transplantation AB is a Swedish biotechnology company headquartered in Uppsala. It owns GlycoMab, a patented technology used to create antibodies that are immunosuppressive drugs like Atgam, which the company produces. The company also collaborates with third-party companies for the development and commercialization of other therapies.
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇸🇪 Sweden